fbpx

Oxford Technology Park acquired by Life Science REIT in a £183 million deal

Oxford Technology Park acquired by Life Science REIT in a £183 million deal
The 20-acre Oxford Technology Park was acquired from Angus and Alicia Bates, who have owned and developed the park since 2007.

Oxford Technology Park (OTP), a 20-acre science and technology park, has been acquired by Life Science REIT, a real estate investment trust focused on UK life science properties, in a £183 million deal.

OTP is located less than 2 miles from Oxford University’s Begbroke Science Park campus, 7 miles north of Oxford city centre and adjacent to Oxford Airport. The first buildings in the park are already complete and delivering rental income, and when fully developed, it will comprise up to 450,000 sq ft of mixed-use life science space and amenity assets.

OTP was acquired for a purchase price of £120.3m from Angus and Alicia Bates, who have owned and developed the park since 2007. The acquisition includes OTP’s debt of £33.8m, and the Life Science REIT will also provide up to £62.7m of forward funding to complete the park’s build-out, which will continue to be managed by the developer until practical completion. The initial consideration was funded by the Life Science REIT’s existing cash resources.

The park provides a unique combination of space and amenity facilities, with flexibility for laboratory, production and office use required for life science occupiers. Unit sizes range from 6,000 to 50,000 sq ft providing a full spectrum of options for potential occupiers. Headline rents are £16 to £20 per sq ft for hybrid space and £28 per sq ft for offices, reflecting a net initial yield on purchase of 4.75%.

The first two of OTP’s 11 units are already complete, with one fully let to LGC’s The Native Antigen Company (TNAC), one of the world’s leading suppliers of high-quality infectious disease reagents, at a headline rent of £16 per sq ft. Five units are due for completion in 2022, and the final four units in 2023. The acquisition also includes a completed hotel that is let to leading provider Premier Inn until 2045. There is strong interest in all of the buildings currently under construction.

All of the equity proceeds from Life Science REIT ’s oversubscribed IPO in November 2021 have now been invested into seven high-quality transactions with a total acquisition value of £383m.

Life Science REIT now has an attractive blend of projects diversified by development stage, location and asset size. This includes immediate income-producing assets, significant conversion opportunities, and new build developments in a balanced portfolio of properties in Oxford, Cambridge and London.

Simon Farnsworth, Managing Director of Ironstone Asset Management Ltd, Investment Advisers to Life Science REIT, said: “There is virtually no new supply of this type, size and quality of space in the Oxford catchment, and we are delighted to have secured such an important and strategic asset of scale for our shareholders.

“It has been great to work with Angus and his team, whose vision and hard work has resulted in this opportunity to provide state of the art space for new and established businesses in the area. We look forward to creating a thriving hub of innovation in this perfectly situated asset for the rapidly growing Oxford life science community.”

Angus Bates, CEO of the developer, Oxtec Developments Limited, commented: “Taking the vision to create OTP fifteen years ago through to the successful high-tech park that is now evolving has been challenging and hugely fulfilling, providing a unique product to the Oxford science community. We are thrilled to be handing the reins over to Life Science REIT and their experienced management team to take the park forward to the next stage.

Trending news

Latest news